77 related articles for article (PubMed ID: 20229604)
1. Lack of appreciable species differences in nonspecific microsomal binding.
Zhang Y; Yao L; Lin J; Gao H; Wilson TC; Giragossian C
J Pharm Sci; 2010 Aug; 99(8):3620-7. PubMed ID: 20229604
[TBL] [Abstract][Full Text] [Related]
2. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
Obach RS
Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
[TBL] [Abstract][Full Text] [Related]
3. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
Deshmukh SV; Harsch A
J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
[TBL] [Abstract][Full Text] [Related]
4. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.
Austin RP; Barton P; Cockroft SL; Wenlock MC; Riley RJ
Drug Metab Dispos; 2002 Dec; 30(12):1497-503. PubMed ID: 12433825
[TBL] [Abstract][Full Text] [Related]
5. Application of the fluorescent probe 1-anilinonaphthalene-8-sulfonate to the measurement of the nonspecific binding of drugs to human liver microsomes.
McLure JA; Birkett DJ; Elliot DJ; Williams JA; Rowland A; Miners JO
Drug Metab Dispos; 2011 Sep; 39(9):1711-7. PubMed ID: 21610127
[TBL] [Abstract][Full Text] [Related]
6. Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomes.
Poulin P; Haddad S
J Pharm Sci; 2011 Oct; 100(10):4501-17. PubMed ID: 21574165
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of methoxymorpholino-doxorubicin in rat, dog and monkey liver microsomes: comparison with human microsomes.
Beulz-Riche D; Robert J; Menard C; Ratanasavanh D
Fundam Clin Pharmacol; 2001 Dec; 15(6):373-8. PubMed ID: 11860524
[TBL] [Abstract][Full Text] [Related]
8. Non-specific binding of compounds in
Gardner I; Xu M; Han C; Wang Y; Jiao X; Jamei M; Khalidi H; Kilford P; Neuhoff S; Southall R; Turner DB; Musther H; Jones B; Taylor S
Xenobiotica; 2022 Aug; 52(8):943-956. PubMed ID: 36222269
[TBL] [Abstract][Full Text] [Related]
9. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
Eberhart DC; Gemzik B; Halvorson MR; Parkinson A
Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247
[TBL] [Abstract][Full Text] [Related]
10. Species differences in the hepatic microsomal oxidation of nalidixic acid.
Harvey F; Edelson J
Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):192-8. PubMed ID: 413504
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
12. Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species Surrogate.
Barr JT; Lade JM; Tran TB; Dahal UP
Drug Metab Dispos; 2019 Apr; 47(4):419-423. PubMed ID: 30733251
[TBL] [Abstract][Full Text] [Related]
13. The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application.
Wong H; Grossman SJ; Bai SA; Diamond S; Wright MR; Grace JE; Qian M; He K; Yeleswaram K; Christ DD
Drug Metab Dispos; 2004 Dec; 32(12):1359-69. PubMed ID: 15333515
[TBL] [Abstract][Full Text] [Related]
14. [In vitro comparison of thienorphine metabolism in liver microsomes of human, Beagle dog and rat].
Deng JT; Zhuang XM; Li H
Yao Xue Xue Bao; 2010 Jan; 45(1):98-103. PubMed ID: 21351457
[TBL] [Abstract][Full Text] [Related]
15. [In vivo comparison of estradiol metabolism in liver microsomes of human, Beagle dog and rat].
Song YQ; Liao J; Liu HW; Ai CH; Zhang F
Yao Xue Xue Bao; 2012 Feb; 47(2):210-5. PubMed ID: 22512033
[TBL] [Abstract][Full Text] [Related]
16. Structure-based prediction of the nonspecific binding of drugs to hepatic microsomes.
Li H; Sun J; Sui X; Yan Z; Sun Y; Liu X; Wang Y; He Z
AAPS J; 2009 Jun; 11(2):364-70. PubMed ID: 19440845
[TBL] [Abstract][Full Text] [Related]
17. Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM-IDA-EPI method.
Lee JY; Lee SY; Lee K; Oh SJ; Kim SK
Chem Biol Interact; 2015 Mar; 229():109-18. PubMed ID: 25623954
[TBL] [Abstract][Full Text] [Related]
18. Comparative metabolism of cinobufagin in liver microsomes from mouse, rat, dog, minipig, monkey, and human.
Ma XC; Ning J; Ge GB; Liang SC; Wang XL; Zhang BJ; Huang SS; Li JK; Yang L
Drug Metab Dispos; 2011 Apr; 39(4):675-82. PubMed ID: 21205911
[TBL] [Abstract][Full Text] [Related]
19. The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.
Zhao XJ; Ishizaki T
J Pharmacol Exp Ther; 1997 Dec; 283(3):1168-76. PubMed ID: 9399990
[TBL] [Abstract][Full Text] [Related]
20. In vitro investigation of the hepatic intrinsic clearance of apicidin, a histone deacetylase inhibitor, in mouse, rat, and human, with correction by nonspecific protein binding.
Shin BS; Park EH; Yoon CH; Kim J; Zee O; Yoo SD
J Toxicol Environ Health A; 2005 Dec; 68(23-24):2207-18. PubMed ID: 16326434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
